{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:22Z","timestamp":1786123402139,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Opioids are frequently used in chronic pain management but are associated with significant morbidity and mortality in some patient populations. An important avenue for identifying complications\u2014including serious or rare complications\u2014is the study of closed malpractice claims. The present study is intended to complement the existing closed claims literature by drawing on claims from a more recent timeframe through a partnership with a large malpractice carrier, the Controlled Risk Insurance Company (CRICO). The goal of this study was to identify patient medical comorbidities and aberrant drug behaviors, as well as prescriber practices associated with patient injury and malpractice claims. Another objective was to identify claims most likely to result in payments and use this information to propose a strategy for reducing medicolegal risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The CRICO Strategies Comparative Benchmarking System is a database of claims drawing from &gt;350,000 malpractice claims from Harvard-affiliated institutions and &gt;400 other academic and community institutions across the United States. This database was queried for closed claims from January 1, 2009, to December 31, 2013, and identified 37 cases concerning noninterventional, outpatient chronic pain management. Each file consisted of a narrative summary, including expert witness testimony, as well as coded fields for patient demographics, medical comorbidities, the alleged damaging event, the alleged injurious outcome, the total financial amount incurred, and more. We performed an analysis using these claim files.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The mean patient age was 43.5 years, with men representing 59.5% of cases. Payments were made in 27% of cases, with a median payment of $72,500 and a range of $7500\u2013$687,500. The majority of cases related to degenerative joint disease of the spine and failed back surgery syndrome; no patients in this series received treatment of malignant pain. Approximately half (49%) of cases involved a patient death. The use of long-acting opioids and medical conditions affecting the cardiac and pulmonary systems were more closely associated with death than with other outcomes. The nonpain medical conditions present in this analysis included obesity, obstructive sleep apnea, chronic obstructive pulmonary disease, hypertension, and coronary artery disease. Other claims ranged from alleged addiction to opioids from improper prescribing to alleged abandonment with withdrawal of care. The CRICO analysis suggested that patient behavior contributed to over half of these claims, whereas deficits in clinical judgment contributed to approximately 40% of the claims filed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Claims related to outpatient medication management in pain medicine are multifactorial, stemming from deficits in clinical judgment by physicians, noncooperation in care by patients, and poor clinical documentation. Minimization of both legal risk and patient harm can be achieved by carefully selecting patients for chronic opioid therapy and documenting compliance and improvement with the treatment plan. Medical comorbidities such as obstructive sleep apnea and the use of long-acting opioids may be particularly dangerous. Continuing physician education on the safest and most effective approaches to manage these medications in everyday practice will lead to both improved legal security and patient safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002499","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T10:51:29Z","timestamp":1508496689000},"page":"1761-1768","source":"Crossref","is-referenced-by-count":16,"title":["A Contemporary Medicolegal Analysis of Outpatient Medication Management in Chronic Pain"],"prefix":"10.1213","volume":"125","author":[{"given":"Christopher R.","family":"Abrecht","sequence":"first","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan Y.","family":"Brovman","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Song","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Rathmell","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.2014.12986","article-title":"Relieving pain in America: insights from an Institute of Medicine committee.","volume":"312","author":"Dzau","year":"2014","journal-title":"JAMA"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MLR.0b013e3182a95d86","article-title":"Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.","volume":"51","author":"Daubresse","year":"2013","journal-title":"Med Care"},{"key":"R3-20230721","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","article-title":"Prescription drug overdoses: a review.","volume":"43","author":"Paulozzi","year":"2012","journal-title":"J Safety Res"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0889-8537(02)00006-8","article-title":"The Closed Claims Project. Has it influenced anesthetic practice and outcome?","volume":"20","author":"Lee","year":"2002","journal-title":"Anesthesiol Clin North America"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/ALN.0b013e3181cdef98","article-title":"Malpractice claims associated with medication management for chronic pain.","volume":"112","author":"Fitzgibbon","year":"2010","journal-title":"Anesthesiology"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1213\/ANE.0000000000001702","article-title":"A contemporary medicolegal analysis of implanted devices for chronic pain management.","volume":"124","author":"Abrecht","year":"2017","journal-title":"Anesth Analg"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practice and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/ALN.0b013e3181cdef98","article-title":"Malpractice claims associated with medication management for chronic pain.","volume":"112","author":"Fitzgibbon","year":"2010","journal-title":"Anesthesiology"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/ALN.0000000000000855","article-title":"Trends in pain medicine liability.","volume":"123","author":"Pollak","year":"2015","journal-title":"Anesthesiology"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5664\/jcsm.26908","article-title":"Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing.","volume":"3","author":"Walker","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5664\/jcsm.5704","article-title":"Medium increased risk for central sleep apnea but not obstructive sleep apnea in long-term opioid users: a systematic review and meta-analysis.","volume":"12","author":"Filiatrault","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5664\/jcsm.3950","article-title":"Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapy.","volume":"10","author":"Rose","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/BRS.0000000000000249","article-title":"Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane review.","volume":"39","author":"Chaparro","year":"2014","journal-title":"Spine (Phila Pa 1976)"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/ALN.0000000000000564","article-title":"Postoperative opioid-induced respiratory depression: a closed claims analysis.","volume":"122","author":"Lee","year":"2015","journal-title":"Anesthesiology"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","article-title":"Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain.","volume":"129","author":"Edlund","year":"2007","journal-title":"Pain"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AJP.0b013e3180330dc5","article-title":"Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.","volume":"23","author":"Wasan","year":"2007","journal-title":"Clin J Pain"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system.","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpain.2007.02.432","article-title":"Substance use disorders in a primary care sample receiving daily opioid therapy.","volume":"8","author":"Fleming","year":"2007","journal-title":"J Pain"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1526-4637.2012.01518.x","article-title":"Risk factors for prescription opioid-related death, Utah, 2008-2009.","volume":"13","author":"Lanier","year":"2012","journal-title":"Pain Med"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain.","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines.","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010.","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamainternmed.2014.6294","article-title":"Out-of-hospital mortality among patients receiving methadone for noncancer pain.","volume":"175","author":"Ray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R31-20230721","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief\u2014United States, 1999\u20132010.","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.331.7529.1352","article-title":"Is methadone too dangerous for opiate addiction?","volume":"331","author":"Luty","year":"2005","journal-title":"BMJ"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.36076\/ppj.2017.s109","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1.","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"R34-20230721","first-page":"S111","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2).","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"R37-20230721","first-page":"34","article-title":"Patient abandonment: from a legal perspective\u2013a new series on physician-patient relationships.","volume":"14","author":"Hirsh","year":"1985","journal-title":"Urban Health"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1526-4637.2010.00938.x","article-title":"Medical malpractice allegations of iatrogenic addiction in chronic opioid analgesic therapy: forensic case reports.","volume":"11","author":"Fishbain","year":"2010","journal-title":"Pain Med"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1526-4637.2009.00620.x","article-title":"Alleged medical abandonment in chronic opioid analgesic therapy: case report.","volume":"10","author":"Fishbain","year":"2009","journal-title":"Pain Med"},{"issue":"suppl 2","key":"R40-20230721","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1526-4637.2011.01134.x","article-title":"An analysis of the root causes for opioid-related overdose deaths in the United States.","volume":"12","author":"Webster","year":"2011","journal-title":"Pain Med"},{"issue":"suppl 2","key":"R41-20230721","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1526-4637.2011.01129.x","article-title":"A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose.","volume":"12","author":"Rich","year":"2011","journal-title":"Pain Med"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00000542-199908000-00030","article-title":"The American Society of Anesthesiologists Closed Claims Project: what have we learned, how has it affected practice, and how will it affect practice in the future?","volume":"91","author":"Cheney","year":"1999","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201711000-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:19Z","timestamp":1786112779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201711000-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002499","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}